Cipla and Stempeutics launch Ciplostem, a DCGI-approved cell therapy for Grade II–III Knee Osteoarthritis, offering long-term ...

Cold weather intensifies joint pain for Osteoarthritis sufferers due to reduced blood flow. While OA is irreversible, ...

More patients are presenting to emergency departments with infected knees after being injected with hyaluronic acid.

Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...

Cipla partners with Stempeutics to launch Ciplostem, a new therapy for Knee Osteoarthritis approved by DCGI. Targets disease ...

Shoulder issues are more common in women, especially after age 40. They are also associated with medical conditions such as ...

An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee ...

Osteoarthritis is the most common joint disease worldwide. How to prevent it and why surgery should be the last ...

How to distinguish arthritis from ‘muscle fatigue’, a confusion that invariably delays treatment and risks permanent joint ...

Two ACR 2025 analyses link SGLT2 inhibitors to fewer RA flares and a lower risk for osteoarthritis than GLP-1 receptor ...

Knee injuries are common in athletes, accounting for 41% of all athletic injuries. But knee injuries aren’t limited to ...

This article is sponsored by Centers Health Care. In this Voices interview, Skilled Nursing News sits down with Dr. Matthew ...